TickerFactsScreenerDevelopers

Oncotelic Therapeutics, Inc. (OTLC) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$31.16M2010: -$18.51M2011: -$11.89M2012: -$8.07M2013: -$8.28M2014: -$12.65M2015: -$13.68M2016: -$13.76M2017: -$13.84M2018: -$712.7K2019: -$4.31M2020: -$7.58M2021: -$9.13M2022: -$9.72M2023: -$6.65M2024: -$3.58M2025: -$3.19M-$3.19M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$3.19M+10.9%
2024-$3.58M+46.2%
2023-$6.65M+31.6%
2022-$9.72M-6.5%
2021-$9.13M-20.3%
2020-$7.58M-75.9%
2019-$4.31M-504.8%
2018-$712.7K+94.9%
2017-$13.84M-0.6%
2016-$13.76M-0.6%
2015-$13.68M-8.2%
2014-$12.65M-52.8%
2013-$8.28M-2.6%
2012-$8.07M+32.1%
2011-$11.89M+35.8%
2010-$18.51M+40.6%
2009-$31.16M—